JMP Securities Downgrades InterMune Inc. (ITMN) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/3/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
- Analysis-Excommunications show a Pope Leo unafraid of making firm decisions
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Canaccord Starts Infleqtion, Inc (INFQ) at Buy
- Jersey Mike's Subs files for IPO on NYSE under ticker JMKE
- Meta CEO Mark Zuckerberg Says In Internal Town Hall That Ai Agent Development Over The Last Four Months Hasn't 'accelerated In The Way We Expected' - Reuters
UBS Downgrades InterMune Inc. (ITMN) to Neutral
August 28, 2014 6:40 AM EDTUBS downgraded InterMune Inc. (NASDAQ: ITMN) from Buy to Neutral.
For an analyst ratings summary and ratings history on InterMune Inc. click here. For more ratings news on InterMune Inc. click here.
Shares of InterMune Inc. closed at $73.18 yesterday.
... MoreJPMorgan Downgrades InterMune Inc. (ITMN) to Neutral
August 26, 2014 6:49 AM EDTJPMorgan downgraded InterMune Inc. (NASDAQ: ITMN) from Overweight to Neutral with a price target of $74.00.
For an analyst ratings summary and ratings history on InterMune Inc. click here. For more ratings news on InterMune Inc. click here.
Shares of InterMune Inc. closed at $72.85 yesterday.
... MoreRoche to Acquire InterMune (ITMN) in $8.3 Billion Deal
August 24, 2014 12:26 PM EDTAs had been rumored the past few weeks, Swiss drug giant Roche (OTC: RHHBY) agreed to acquire InterMune (NASDAQ: ITMN) $74.00 per share in cash, or a 38% premium to Friday's market close. The transaction is worth $8.3 billion on a fully diluted basis.
The merger agreement has been approved by the boards of InterMune and Roche.
Roche will commence a tender offer no later than August 29, 2014, to acquire all outstanding shares of InterMune common stock, and InterMune will... More
